Fɔ bɔku uman dɛn, di tɛm we dɛn kin lɛf fɔ gɛt bɛlɛ, we na di tɛm we di mɔnt kin stɔp we dɛn de ol, kin tranga. Bɔrku pipul kin fil nɔr kin fil fayn bikɔs ɔf tin dɛm lɛk wam wam wam wam wam wam wam wam wam wam wam wam wam wam wam wam wam wam wayn, wae dɛn kin swet ɔltɛm, ɛn nɔr kin slip fayn. So, wan pɔpul tritmɛnt wae dɔktɔ dɛn kin se fɔ kɔntrol dɛn sik ya na Ɔmon Riplesmɛnt Tɛrapi (HRT). Bɔt bɔku pipul dɛn kin gɛt kwɛstyɔn ɛn fred bɔt dis HRT tritmɛnt, mɔ bɔt if i kin mek dɛn gɛt bɔdi kansa. Lɛ wi tɔk bɔt ɔltin klia wan ɛn simpul wan tide.
Wetin na HRT? Wetin i de du?
Fɔ tɔk am simpul wan, di tɛm we uman in bɔdi nɔ kin gɛt bɛtɛ ɛstrojen ɛn prɔjɛstin. HRT na tritmɛnt we de tek dɛn ɔmon ya in ples we dɛn de tek mɛrɛsin. Dis kin ɛp fɔ kɔntrol di sayn dɛn we pɔsin kin gɛt we i dɔn pas 40 ia.
Tu men kayn HRT de:
1. Kɔmbayn HRT ( ɛstrojen ɛn prɔjɛstin ): Dɛn kin gi dis kayn to bɔku uman dɛn we dɛn nɔ pul dɛn uterus. dis na biכs if yu tek εstrojen nכmכ i kin mek yu gεt uterin kεnsar. Di prɔjɛstin ɔmon de ridyus da risk de.
2. HRT we de yuz εstrojen nכmכ: dεn kin gi dis to uman dεm we dεn dכn hysterectomy biכs dεn nכ de pan risk fכ uterin kεnsar.
Yu tink se rili gɛt sɔntin fɔ du wit HRT ɛn di risk fɔ gɛt bɔdi kansa?
Yɛs, risach dɔn sho se sɔntin de we gɛt fɔ du wit sɔntin. Di impɔtant ɛn big stɔdi bɔt dis na di Women’s Health Initiative (WHI). Di tin dɛn we bin apin bin rili impɔtant.
Da risach de sho se uman dɛn we de tek ɔl tu di ɔmon dɛn we dɛn kɔl ɛstrojen ɛn prɔjɛstin (Combined HRT) kin gɛt kansa na dɛn bɔdi smɔl .
Nɔto dat nɔmɔ, bɔt ɔda siriɔs prɔblɛm de. dis כmon tεrapi de mek di brεst tisu tik. Dɔn, di kɔrɛkt we aw di mammogram tɛst we wi kin yuz fɔ no bɔt bɔdi kansa kwik kin go dɔŋ. Dat min se ivin if kansa kam, dɛn nɔ go no am te i dɔn go bifo.
Bɔt dis risach dɔn sho bak se di risk fɔ gɛt bɔdi kansa pan uman dɛn we dɛn pul dɛn uterus ɛn tek HRT we gɛt ɛstrojen nɔmɔ nɔ kin bɔku .
Wetin na di gud ɛn bad tin dɛn we pɔsin kin du we i tek HRT?
Lɛk ɛni tritmɛnt, HRT gɛt bɛnifit ɛn bad tin dɛn. I impɔtant fɔ tɔk bɔt dɛn tu tin ya wit yu dɔktɔ ɛn ɔndastand dɛn gud gud wan bifo yu disayd fɔ du sɔntin.
| Di kayn tritmɛnt we dɛn kin gi | Men advantej dɛn | Men risk dɛn |
|---|---|---|
| Ɛstrojen + Prɔjɛstin (Kɔmbayn HRT) . (Fɔ uman dɛn we gɛt uterus) | I kin kɔntrol di simptom dɛm we pɔsin kin gɛt we i de menɔpauz fayn fayn wan (lɛk wam wam wam bɔdi wam). | - Di risk fɔ gɛt bɔdi kansa de bɔku. - Di risk fɔ gɛt at sik kin bɔku. - Di risk fɔ gɛt strok de bɔku. - Risk fɔ mek blɔd klɔt. |
| HRT we gɛt ɛstrojen nɔmɔ (Fɔ uman dɛn we dɛn dɔn pul dɛn uterus) | I de kɔntrol di simptom dɛn we pɔsin kin gɛt we i dɔn pas 18 ia fayn fayn wan. | - Di risk fɔ gɛt bɔdi kansa nɔ kin bɔku. - Bɔt di risk fɔ strok ɛn blɔd klɔt stil de. |
So, di disayd fɔ bigin HRT na di disizhɔn we yu fɔ disayd togɛda wit yu dɔktɔ, ɛn tek bɔku tin dɛn lɛk yu yon wɛlbɔdi, aw yu sik bad bad wan, ɛn yu famili mɛdikal istri .
HRT fayn fɔ pɔsin we dɔn wɛl frɔm bɔdi kansa?
Dis na tin we rili sɛnsitiv. Trade, dɛn bin de gi HRT bak to uman dɛn we dɔn wɛl frɔm brɔst kansa fɔ kɔntrol di simptom dɛn we dɛn kin gɛt we dɛn nɔ gɛt bɛlɛ. Bɔt wan stɔdi we dɛn bin du insay 2004 we dɛn kɔl HABITS sho se di wan dɛn we gɛt kansa ɛn we tek HRT kin gɛt mɔ risk fɔ gɛt kansa bak ɔ gɛt nyu kansa.
So, naw, dɔktɔ dɛn biliv se i rili bad fɔ gi HRT to uman dɛn we dɔn wɛl frɔm bɔdi kansa.
Wetin na di ɔda tin dɛn we dɛn kin du pas HRT fɔ mek di bon dɛn strɔng?
We di uman dɔn pas we uman dɔn pas 40 ia, i kin gɛt mɔ risk fɔ gɛt ɔstioporosis, we na wan sik we kin mek di bon dɛn tan ɛn brok. Wan tɛm dɛn bin dɔn rɛkɔmɛnd HRT fɔ dis bak. Bɔt naw, bikɔs ɔf dɛn risk dɛn de, ɔda we dɛn de we sef ɛn we go wok fayn.
- Bisphosphonates: Dis na di kayn mɛrɛsin we dɛn kin gi fɔ ɔstioporosis.
- Ɔda mɛrɛsin dɛn: Di dɔktɔ kin gi yu ɔda mɛrɛsin dɛn bak lɛk Abaloparatide , Denosumab, Romosozumab, ɛn Teriparatide.
- SERM dεm (Selective Estrogen Receptor Modulators): Dis na nyu klas fכ drog dεm we de wok lεk εstrojen. Dɛn kin mek di bon dɛn bɔku ɛn protɛkt frɔm ɔstioporosis, ɛn dɛn kin protɛkt bak frɔm bɔdi kansa. Raloxifene (Evista) na wan pɔpul drɔg we gɛt dis kayn mɛrɛsin. Bɔt dɛn tin ya nɔ de ridyus di simptom dɛm we pɔsin kin gɛt we i de menɔpaus (hot flash), ɛn i kin ivin mek i bɔku.
Tin dɛm wae yu kin du fɔ bon wɛl bɔdi apat frɔm mɛrɛsin
Apat frɔm di mɛrɛsin dɛn, di we aw yu de liv yu layf kin du bɔku tin bak fɔ mek yu bon dɛn strɔng.
- Ɛksesaiz fɔ bia wet: Ɛksesaiz lɛk fɔ waka, rɔn, ɛn fɔ klaym stej.
- Fɔ tek kalsiɔm ɛn vaytamɛn D sɔpɔtmɛnt: Aks yu dɔktɔ ɛn bigin if nid de.
- Nɔ smok: Fɔ smok kin rili ambɔg yu bon.
- Fɔ avɔyd fɔ drink rɔm pasmak.
Mɛsej we dɛn kin kɛr go na os
- Ɔmon riplesmɛnt tɛrapi (HRT) na wan tritmɛnt we rili fayn fɔ di sik dɛn we pɔsin kin gɛt we i dɔn pas 40 ia, bɔt prɔblɛm dɛn de we kin apin to am.
- We dɛn put HRT togɛda, we gɛt ɛstrojen ɛn prɔjɛstin , i kin mek pɔsin gɛt kansa na in bɔdi, at sik, strok, ɛn blɔd we kin rɔtin.
- Estrogen-only HRT fɔ uman dɛn we dɛn dɔn pul dɛn uterus de ridyus di risk fɔ gɛt bɔdi kansa, bɔt di risk fɔ strok ɛn blɔd klɔt stil de.
- Di disayd fɔ tek HRT ɔ nɔ tek am na sɔntin we pɔsin kin disayd fɔ du. Dis disishun fɔ bi afta yu dɔn tek tɛm tɔk bɔt ɔl di gud ɛn bad tin dɛn wit yu dɔktɔ.
- If yu dɔn wɛl frɔm brɔst kansa, dɛn nɔ kin fayn fɔ gi yu HRT tritmɛnt.
- Ɔda mɛrɛsin dɛn de we sef ɛn we go wok fayn ɛn chenj dɛn layf fɔ protɛkt bon wɛlbɔdi (Osteoporosis) instead ɔf HRT.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt